1408075-36-4 Usage
Uses
Used in Pharmaceutical Research:
(1S,2S,5S)-8-Aza-bicyclo[3.2.1]octane-2-carboxylic acid is used as a chiral building block for the development of new pharmaceutical compounds. Its unique structure allows for the creation of enantiomerically pure drugs, which can have different biological activities and reduce potential side effects.
Used in Drug Synthesis:
(1S,2S,5S)-8-Aza-bicyclo[3.2.1]octane-2-carboxylic acid is used as a precursor in the synthesis of other organic compounds with potential biological activity. Its versatile structure enables the development of a wide range of pharmaceutical agents with diverse therapeutic effects.
Used in Medicinal Chemistry:
(1S,2S,5S)-8-Aza-bicyclo[3.2.1]octane-2-carboxylic acid is utilized in medicinal chemistry for the study of its potential therapeutic effects. Researchers are investigating its interactions with biological targets and exploring its potential as a lead compound for the development of new medications.
Overall, (1S,2S,5S)-8-Aza-bicyclo[3.2.1]octane-2-carboxylic acid is a promising compound with a wide range of applications in the pharmaceutical industry, from drug synthesis to medicinal research and development.
Check Digit Verification of cas no
The CAS Registry Mumber 1408075-36-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,0,8,0,7 and 5 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1408075-36:
(9*1)+(8*4)+(7*0)+(6*8)+(5*0)+(4*7)+(3*5)+(2*3)+(1*6)=144
144 % 10 = 4
So 1408075-36-4 is a valid CAS Registry Number.
1408075-36-4Relevant academic research and scientific papers
Fmoc-protected tropane-based amino acids for peptide structure-function studies
Thompson, Philip E.,Hearn, Milton T. W.
, p. 2907 - 2910 (2007/10/03)
Cyclic amino acids derived from the tropane alkaloid nucleus have been prepared and incorporated into synthetic peptides. These conformationally constrained β-amino acids hold considerable potential for use in the development of novel, synthetic analogues of biologically active peptides.
